Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospital, Basel, Switzerland
This study is to identify rare, disease-causing mutations of several rare neutrophil dermatoses. To identify associations between NMID and variants in the genome next generation sequencing, mainly whole exome sequencing, will be used. In a second approach the expression level of already known inflammatory proteins in skin samples will be investigated.
written consent of the participating person
diagnosis of a disease in the NMID form group or proband of the control group
Missing informed consent if samples collected after 2014
no diagnosis of NMID
Missing informed consent